Viewing Study NCT07481058


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 2:31 AM
Study NCT ID: NCT07481058
Status: RECRUITING
Last Update Posted: 2026-03-20
First Post: 2026-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module